Table 3.
Change in fatigue perpetuating factors
| CBT-TTF (N = 22) | WLC (N = 14) | d value | p value | |||
|---|---|---|---|---|---|---|
| Baseline | Follow-up | Baseline | Follow-up | |||
| M (SD) [range] | M (SD) [range] | M (SD) [range] | M (SD) [range] | |||
| Sleep | ||||||
| Sleep/wake dysregulation (SIP-SR) | 183.6 (150.9) [0–499] | 54.5 (90.3) [0–395] | 195.4 (98.7) [49–395] | 144.5 (100.1) [0–335] | −.51 | .134 |
| Activity | ||||||
| Mental activity (CIS − concentration) | 23.9 (6.7) [7–35] | 14.5 (6.9) [5–29] | 22.5 (7.8) [6–34] | 20.3 (9.4) [9–34] | −.86 | .015 |
| Physical activity (IPAQ – total METS) | 1760.3 (2119.0) [0-7866] | 4031.3 (4154.7) [198–12,945] | 2046.3 (3336.8) [0−12,240] |
1420.1 (2146.5) [0−7,038] | −.80 | .023 |
| Social Activity (SIP-SI)a | 513.9 (266.1) [135–1,091] | 108.6 (162.4) [0–652] | 562.8 (274.5) [190–997] | 524.2 (294.5) [103–973] | −1.14 | .001 |
| Cognitions | ||||||
| Self-efficacy (SES) | 17.7 (3.2) [11–24] | 21.4 (2.7) [14–24] | 18.4 (3.0) [13–23] | 19.1 (3.3) [13–24] | 1.19 | .001 |
| Fatigue catastrophizing (FCS) | 13.7 (6.5) [1–24] | 4.9 (6.3) [0–29] | 8.6 (5.4) [0–17] | 7.1 (5.8) [1–22] | −1.22 | <.001 |
| Helplessness (ICQ) | 14.1 (4.2) [6–22] | 8.5 (3.5) [6–18] | 13.4 (3.8) [8–19] | 12.4 (3.8) [6–19] | −1.05 | .003 |
| Focusing on symptoms (IMQ) | 19.0 (6.9) [6–30] | 8.7 (6.0) [0–24] | 18.1 (9.0) [9–37] | 16.5 (7.8) [6–35] | −1.28 | <.001 |
| Processing | ||||||
| Intrusive thoughts (IES-I) | 8.9 (7.3) [0–23] | 4.6 (5.8) [0–22] | 10.2 (7.0) [1–23] | 8.1 (6.2) [1–25] | −.33 | .320 |
| Avoidance (IES-A) | 13.8 (10.6) [0–32] | 6.9 (7.1) [0–22] | 16.4 (8.6) [6–32] | 15.4 (8.4) [4–32] | −.61 | .073 |
| Social | ||||||
| Social interaction (SSL-I) | 18.5 (5.6) [9–28] | 20.0 (4.9) [10–28] | 16.9 (3.2) [12–22] | 18.0 (3.3) [13–26] | .07 | .853 |
| Negative interaction (SSL-N) | 10.0 (2.5) [7 – 17] | 9.0 (2.7) [7–16] | 11.0 (4.6) [7–20] | 10.1 (3.1) [7–18] | −.03 | .912 |
| Discrepancy (SSL-D) | 11.5 (3.5) [8 – 21] | 9.4 (3.6) [8–24] | 13.3 (4.8) [8–24] | 11.6 (3.5) [8–18] | −.07 | .826 |
| Fear of progression | ||||||
| Cancer-related worry (CWS – 5 items) | 9.9 (2.4) [5–15] | 8.2 (1.8) [5–11] | 9.6 (3.8) [5–16] | 9.6 (1.9) [6–13] | −.65 | .058 |
Note: CBT-TTF, cognitive-behavioral therapy for targeted therapy-related fatigue; WLC, waitlist control.
d values refer to effect size of magnitude of change. p values refer to interaction effect for mixed model (group × time). p values <.05 bolded.
aFor SIP-SI, N = 13 for WLC.